EcoDrugPlus

Coiled-Coil Domain Containing 6b

Ensembl ID : ENSIPUG00000008375
Gene Symbol: CCDC6B
3 Cross references
151 Possible Orthologues:

Collagenase 3

Ensembl ID : ENSIPUG00000020884
Gene Symbol: LOC108276916
2 Cross references
289 Possible Orthologues:

Colony Stimulating Factor 1 Receptor, B

Ensembl ID : ENSIPUG00000018251
Gene Symbol: CSF1RB
2 Cross references
201 Possible Orthologues:

Complement Component 5

Ensembl ID : ENSIPUG00000016789
Gene Symbol: C5
2 Cross references
216 Possible Orthologues:

Complement Factor D (Adipsin)

Ensembl ID : ENSIPUG00000006895
Gene Symbol: CFD
3 Cross references
133 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSIPUG00000000305
Gene Symbol: CRHR1
4 Cross references
195 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSIPUG00000023385
Gene Symbol: CRHR1
3 Cross references
200 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSIPUG00000014564
Gene Symbol: CCND1
3 Cross references
234 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSIPUG00000015647
Gene Symbol: CDK1
3 Cross references
247 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSIPUG00000012551
Gene Symbol: CDK2
3 Cross references
202 Possible Orthologues:

Cyclin-Dependent Kinase 4

Ensembl ID : ENSIPUG00000000970
Gene Symbol: CDK4
3 Cross references
239 Possible Orthologues:

Cyclin-Dependent Kinase 5

Ensembl ID : ENSIPUG00000000104
Gene Symbol: CDK5
2 Cross references
169 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).